๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Tumor markers of pancreatic carcinoma

โœ Scribed by J. V. Klavins

Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
516 KB
Volume
47
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Clinical use of tumor markers in pancrea
Clinical use of tumor markers in pancreatic carcinoma
โœ Maureen A. Chung; Helena R. Chang ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 473 KB

There is no ideal tumor marker for pancreatic carcinoma. Most of the tumor-associated antigens in this disease are cell surface mucins, such as CA19-9, TAG-72, CA242, CA50, CA195, and CA494. CA19-9 is the most promising marker. It is used for clinical and pathological diagnosis, prognosis, and respo

Tumor markers in patients with pancreati
Tumor markers in patients with pancreatic carcinoma
โœ Anna M. Gattani; John Mandeli; Howard W. Bruckner ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 524 KB

## Background: Tumor markers are putative prognostic indicators for patients with carcinoma, but have not heretofore been evaluated in patients with stage ii and iii pancreatic carcinoma. ## Methods: Patients with stage ii (n=9) and stage iii (n=25) unresectable regional adenocarcinoma of the pan

Immunology, tumor markers, and pancreati
Immunology, tumor markers, and pancreatic cancer
โœ Norman Zamcheck ๐Ÿ“‚ Article ๐Ÿ“… 1975 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 765 KB

## CARCINOEMBRYONIC ANTIGEN Recently, studies have been made of the use and limitations of CEA in diagnosis, detection, and treatment monitoring of patients with pancreatic cancer and related diseases, including acute and chronic pancreatitis. in cancer of the pancreas (1). Subsequently, in an att